Assoc. for Accessible Medicines v. Becerra

  1. February 14, 2025

    Judge Upholds Pay-For-Delay Ban Law, But Only In Calif.

    A California federal judge has upheld part of a new state law that the Association for Accessible Medicines alleged unlawfully restricted "reverse payment" settlements between makers of brand-name and generic drugs, finding that the law's attempt to regulate deals outside of California runs afoul of the Constitution, but is otherwise valid.

  2. February 16, 2022

    Calif. Gets Pay-For-Delay Ban Partially Revived

    A California federal judge on Tuesday partially reinstated the Golden State's ban on most so-called pay-for-delay deals by permitting the prohibition on deals struck within the state but not on those that were inked elsewhere and merely impact drug sales in California.

  3. January 07, 2022

    Calif. Says Stopping Pay-For-Delay Ban Went 'Too Far'

    The state of California told a federal judge that an injunction blocking the Golden State's recent law banning most so-called pay-for-delay deals went "too far" and wants a new ruling that would let the state fight patent settlements with generic drug manufacturers that are inked within the state.

  4. December 09, 2021

    Federal Judge Puts Calif. Pay-For-Delay Ban On Hold

    A California federal judge imposed a temporary block Thursday on the Golden State's recent law banning most so-called pay-for-delay deals, siding with the generic-drug industry's trade association that the measure affects patent litigation settlements with no connection to California.

  5. June 29, 2021

    Ruling Needed Now On Calif. Pay-For-Delay Law, Court Told

    The generic-drug industry's trade association urged a California federal judge Monday to act on its refiled challenge to the Golden State's recent law banning most so-called pay-for-delay deals, arguing the nearly year-old lawsuit has languished long enough.